frog |
LDLo |
parenteral |
4gm/kg (4000mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 50, Pg. 296, 1935. |
man |
LDLo |
unreported |
441mg/kg (441mg/kg) |
? |
"Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970. |
mouse |
LD50 |
intravenous |
610mg/kg (610mg/kg) |
? |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 135, Pg. 330, 1962. |
mouse |
LD50 |
subcutaneous |
2100mg/kg (2100mg/kg) |
? |
Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 161, 1955. |
mouse |
LDLo |
intraperitoneal |
2gm/kg (2000mg/kg) |
? |
Skandinavisches Archiv fuer Physiologie. Vol. 79, Pg. 258, 1938. |
mouse |
LDLo |
oral |
2500mg/kg (2500mg/kg) |
? |
"Narkoseversuche mit Hoheren Alkoholen und Stickstoffderivaten, Dissertation," Leube, F., Pharmakologischen Institut der Universitat Tubingen, Fed. Rep. Ger., 1931Vol. -, Pg. -, 1931. |
rabbit |
LD50 |
oral |
2028mg/kg (2028mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: CORNEAL DAMAGE: EYE
CARDIAC: PULSE RATE
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Industrial Medicine and Surgery. Vol. 41, Pg. 31, 1972. |
rat |
LCLo |
inhalation |
5700ppm/6H (5700ppm) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) |
National Technical Information Service. Vol. OTS0536478, |
rat |
LD50 |
oral |
1gm/kg (1000mg/kg) |
BEHAVIORAL: ATAXIA |
Science. Vol. 116, Pg. 663, 1952. |
rat |
LDLo |
intraperitoneal |
1530mg/kg (1530mg/kg) |
? |
Journal of Industrial Hygiene and Toxicology. Vol. 27, Pg. 1, 1945. |
rat |
LDLo |
rectal |
1400mg/kg (1400mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 49, Pg. 36, 1933. |
rat |
LDLo |
subcutaneous |
1400mg/kg (1400mg/kg) |
? |
Journal of Pharmacology and Experimental Therapeutics. Vol. 49, Pg. 36, 1933. |